Gene therapy for renal diseases: Its potential and limitation

Journal of the American Society of Nephrology

Volumn 14, Issue 4, 2003, Pages 1102-1104

  Imai, Enyu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOVIRUS VECTOR; COLLAGEN TYPE 4; ERYTHROPOIETIN; FAS LIGAND; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RETROVIRUS VECTOR; SCATTER FACTOR;

EDITORIAL; GENE TARGETING; GENE THERAPY; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMAN; KIDNEY DISEASE; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SKELETAL MUSCLE; UREMIA;

EID: 0037378030     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000067655.48829.D5     Document Type: Editorial

References (23)

1. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P: T lymphocyte-directed gene therapy for ADA- SCID: Initial trial results after 4 years. Science 270: 475-480, 1995
2. McCormick F: Cancer gene therapy: Fringe or cutting edge? Nature Rev Cancer 1: 130-141, 2001
3. Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF, Orav EJ, Ehsan A, Dell'Acqua G, Dzau VJ: Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomised, controlled trial. Lancet 354: 1493-1498, 1999
4. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97: 1114-1123, 1998
5. Imai E, Isaka Y: New paradigm of gene therapy: Skeletal-muscle-targeting gene therapy for kidney disease. Nephron 83: 296-300, 1999
6. Yanagihara I, Inui K, Dickson G, Turner G, Piper T, Kaneda Y, Okada S: Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Gene Ther 3: 549-53, 1996
7. Aihara H, Miyazaki J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16: 867-870, 1998
8. Nakamura H, Isaka Y, Tsujie M, Akagi Y, Sudo T, Ohno N, Imai E, Hori M: Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney Int 59: 2134-2145, 2001
9. Furuishi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Tomosugi N, Matsushima K, Egashira K, Yokoyama H: Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14: 1066-1071, 2003
10. Maruyama H, Ataka K, Gejyo F, Higuchi N, Ito Y, Hirahata H, Imazeki I, Ichikawa F, Neichi T, Kikuchi H, Sugawa M, Miyazaki J: Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscle of the normal and uremic rats. Gene Ther 8: 461-468, 2001
11. Zhu G, Nicolson A, Cowley B, Rosen S, Sukhatme V: In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 3: 298-304, 1996
12. Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason: Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome. Gene Ther 3: 21-27, 1996
13. Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M: Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 12: 949-954, 2001
14. Chen S, Agarwal A, Glushakova OY, Jorgensen MS, Salgar SK, Poirier A, Flotte TR, Croker BP, Madsen KM, Atkinson MA, Hauswirth WW, Berns KI, Tisher CC: Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors. J Am Soc Nephrol 14: 947-958, 2003
15. Lehrman S: Virus treatment questioned after gene therapy death. Nature 401: 517-518, 1999
16. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256, 2003
17. Gusella GL, Fedorova E, Hanss B, Marras D, Klotman ME, Klotman PE: Lentiviral gene transduction of kidney. Hum Gene Ther 13: 407-414, 2002
18. Goncalves MA, van der Velde I, Janssen JM, Maassen BT, Heemskerk EH, Opstelten DJ, Knaan-Shanzer S, Valerio D, de Vries AA: Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. J Virol 76: 10734-10744, 2002
19. Heikkila P, Tibell A, Morita T, Chen Y, Wu G, Sado Y, Ninomiya Y, Pettersson E, Tryggvason K: Adenovirus-mediated transfer of type IV collagen α5 chain cDNA into swine kidney in vivo: Deposition of the protein into the glomerular basement membrane. Gene Ther 8: 882-890, 2001
20. Yokoo T, Ohashi T, Utsunomiya Y, Kojima H, Imasawa T, Kogure T, Hisada Y, Okabe M, Eto Y, Kawamura T, Hosoya T: Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells. Hum Gene Ther 10: 2673-2678, 1999
21. Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, Imagawa DK, Goss JA, Busuttil RW, Seu P: Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival. Transplantation 65: 155-160, 1998
22. Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Remuzzi G, Benigni A: CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 11: 747-752, 2000
23. Tsujie M, Isaka Y, Nakamura H, Tanaka T, Ueda N, Hori M, Takahara S, Imai E: Electroporation mediated ex vivo transfection for porcine kidney. J Am Soc Nephrol 12: 666A, 2001